Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model

被引：8

作者：

Molica, Stefano ^{[1
]}

Giannarelli, Diana ^{[2
]}

Visentin, Andrea ^{[3
]}

Reda, Gianluigi ^{[4
]}

Sportoletti, Paolo ^{[5
]}

Frustaci, Anna Maria ^{[6
]}

Chiarenza, Annalisa ^{[7
]}

Ciolli, Stefania ^{[8
]}

Vitale, Candida ^{[9
,10
]}

Laurenti, Luca ^{[11
]}

De Paoli, Lorenzo ^{[12
]}

Murru, Roberta ^{[13
]}

Gentile, Massimo ^{[14
]}

Moia, Riccardo ^{[12
]}

Rigolin, Gian Matteo ^{[15
]}

Levato, Luciano ^{[1
]}

Giordano, Annamaria ^{[16
]}

Del Poeta, Giovanni ^{[17
]}

Stelitano, Caterina ^{[18
]}

Deodato, Marina ^{[6
]}

Ielo, Claudia ^{[19
]}

Noto, Alessandro ^{[4
]}

Guarente, Valerio ^{[5
]}

Coscia, Marta ^{[9
,10
]}

Tedeschi, Alessandra

Gaidano, Gianluca

Cuneo, Antonio

Foa', Robin ^{[19
]}

Trentin, Livio ^{[3
]}

Mauro, Francesca Romana ^{[19
]}

机构：

[1] Azienda Osped Pugliese Ciaccio, Dept Hematol Oncol, Viale Pio X, I-88100 Catanzaro, Italy

[2] Fdn Policlin Univ A Gemelli IRCCS, Biostat Unit, Rome, Italy

[3] Univ Padua, Dept Med, Hematol & Clin Immunol Unit, Padua, Italy

[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[5] Univ Perugia, Dept Med, Ctr Ric Ematooncol CREO, Inst Hematol, Perugia, Italy

[6] ASST Grande Osped Metropolitano Niguarda Milano, Niguarda Canc Ctr, Dept Hematol, Milan, Italy

[7] Ferrarotto Hosp, Div Hematol, Catania, Italy

[8] Careggi Hosp, Hematol Unit, Florence, Italy

[9] Univ Turin, AOU Citta Salute & Sci Torino, Div Hematol, Turin, Italy

[10] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy

[11] Fdn Policlin Univ A Gemelli IRCCS, Inst Haematol, Rome, Italy

[12] Univ Piemonte Orientale, Dept Translat Med, Div Hematol, Novara, Italy

[13] Osped Oncol A Businco AO Brotzu, Hematol & Stem Cell Transplantat Unit, Cagliari, Italy

[14] Hematol & Oncol Dept, Hematol Unit, Cosenza, Italy

[15] St Anna Univ Hosp, Dept Med Sci, Hematol, Ferrara, Italy

[16] Univ Bari, Hematol Sect, Dept Emergency & Organ Transplantat DETO, Bari, Italy

[17] Univ Tor Vergata, Dept Biomed & Prevent, Hematol, Rome, Italy

[18] Grande Osped Metropolitano, Dept Hematol, Reggio Di Calabria, Italy

[19] Sapienza Univ, Dept Translat & Precis Med, Hematol, Rome, Italy

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2022年 / 97卷 / 05期

关键词：

CLL-IPI;

D O I：

10.1002/ajh.26502

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E176 / E180

页数：5

共 15 条

[1]

Ahn IE, 2021, BLOOD, V138, p2642a

[2] Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model [J].

Ahn, Inhye E. ;

Tian, Xin ;

Ipe, David ;

Cheng, Mei ;

Albitar, Maher ;

Tsao, L. Claire ;

Zhang, Lei ;

Ma, Wanlong ;

Herman, Sarah E. M. ;

Gaglione, Erika M. ;

Soto, Susan ;

Dean, James P. ;

Wiestner, Adrian .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06) :576-+

[3] Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials [J].

Allan, John N. ;

Shanafelt, Tait ;

Wiestner, Adrian ;

Moreno, Carol ;

O'Brien, Susan M. ;

Li, Jianling ;

Krigsfeld, Gabriel ;

Dean, James P. ;

Ahn, Inhye E. .

BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (04) :947-953

[4] Treatment of Chronic Lymphocytic Leukemia [J].

Burger, Jan A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05) :460-473

[5] Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI [J].

Delgado, Julio ;

Doubek, Michael ;

Baumann, Tycho ;

Kotaskova, Jana ;

Molica, Stefano ;

Mozas, Pablo ;

Rivas-Delgado, Alfredo ;

Morabito, Fortunato ;

Pospisilova, Sarka ;

Montserrat, Emili .

AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (04) :375-380

[6] Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures [J].

Hallek, Michael ;

Al-Sawaf, Othman .

AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (12) :1679-1705

[7] An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data [J].

Hallek, Michael .

LANCET ONCOLOGY, 2016, 17 (06) :779-790

[8] Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia [J].

Kipps, Thomas J. ;

Fraser, Graeme ;

Coutre, Steven E. ;

Brown, Jennifer R. ;

Barrientos, Jacqueline C. ;

Barr, Paul M. ;

Byrd, John C. ;

O'Brien, Susan M. ;

Dilhuydy, Marie-Sarah ;

Hillmen, Peter ;

Jaeger, Ulrich ;

Moreno, Carol ;

Cramer, Paula ;

Stilgenbauer, Stephan ;

Chanan-Khan, Asher A. ;

Mahler, Michelle ;

Salman, Mariya ;

Eckert, Karl ;

Solman, Isabelle G. ;

Balasubramanian, Sriram ;

Cheng, Mei ;

Londhe, Anil ;

Ninomoto, Joi ;

Howes, Angela ;

James, Danelle F. ;

Hallek, Michael .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (11) :715-+

[9] The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib [J].

Kittai, Adam S. ;

Miller, Cecelia ;

Goldstein, Daniel ;

Huang, Ying ;

Abruzzo, Lynne, V ;

Beckwith, Kyle ;

Bhat, Seema A. ;

Bond, David A. ;

Grever, Michael R. ;

Heerema, Nyla A. ;

Rogers, Kerry A. ;

Ruppert, Amy S. ;

Byrd, John C. ;

Woyach, Jennifer A. .

BLOOD, 2021, 138 (23) :2372-2382

[10] CLL-IPI: valid in the era of oral inhibitors? [J].

Kutsch, Nadine .

BLOOD, 2021, 138 (02) :106-107

← 1 2 →